161 related articles for article (PubMed ID: 12972840)
1. Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries.
Cress RD; Zaslavsky AM; West DW; Wolf RE; Felter MC; Ayanian JZ
Med Care; 2003 Sep; 41(9):1006-12. PubMed ID: 12972840
[TBL] [Abstract][Full Text] [Related]
2. Profiling providers on use of adjuvant chemotherapy by combining cancer registry and medical record data.
Zheng H; Yucel R; Ayanian JZ; Zaslavsky AM
Med Care; 2006 Jan; 44(1):1-7. PubMed ID: 16365606
[TBL] [Abstract][Full Text] [Related]
3. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.
Ayanian JZ; Zaslavsky AM; Fuchs CS; Guadagnoli E; Creech CM; Cress RD; O'Connor LC; West DW; Allen ME; Wolf RE; Wright WE
J Clin Oncol; 2003 Apr; 21(7):1293-300. PubMed ID: 12663717
[TBL] [Abstract][Full Text] [Related]
4. Can cancer registry data be used to study cancer treatment?
Warren JL; Harlan LC
Med Care; 2003 Sep; 41(9):1003-5. PubMed ID: 12972839
[No Abstract] [Full Text] [Related]
5. Combining information from cancer registry and medical records data to improve analyses of adjuvant cancer therapies.
He Y; Zaslavsky AM
Biometrics; 2009 Sep; 65(3):946-52. PubMed ID: 19210743
[TBL] [Abstract][Full Text] [Related]
6. Validity of cancer registry data for measuring the quality of breast cancer care.
Malin JL; Kahn KL; Adams J; Kwan L; Laouri M; Ganz PA
J Natl Cancer Inst; 2002 Jun; 94(11):835-44. PubMed ID: 12048271
[TBL] [Abstract][Full Text] [Related]
7. Do HMO market level factors lead to racial/ethnic disparities in colorectal cancer screening? A comparison between high-risk Asian and Pacific Islander Americans and high-risk whites.
Ponce NA; Huh S; Bastani R
Med Care; 2005 Nov; 43(11):1101-8. PubMed ID: 16224303
[TBL] [Abstract][Full Text] [Related]
8. Bias in completeness of birthplace data for Asian groups in a population-based cancer registry (United States).
Gomez SL; Glaser SL; Kelsey JL; Lee MM
Cancer Causes Control; 2004 Apr; 15(3):243-53. PubMed ID: 15090719
[TBL] [Abstract][Full Text] [Related]
9. Using a Lymph Node Count Metric to Identify Underperforming Hospitals After Rectal Cancer Surgery.
Raoof M; Zafar SN; Ituarte PHG; Krouse RS; Melstrom K
J Surg Res; 2019 Apr; 236():216-223. PubMed ID: 30694758
[TBL] [Abstract][Full Text] [Related]
10. Looking at differences in stage and treatment of colorectal cancers across Italy: a EUROCARE-5 high resolution study.
Minicozzi P; Caldarella A; Giacomin A; Ponz de Leon M; Cesaraccio R; Falcini F; Fusco M; Iachetta F; Pellegri C; Tumino R; Capocaccia R; Sant M
Tumori; 2012 Nov; 98(6):671-7. PubMed ID: 23389351
[TBL] [Abstract][Full Text] [Related]
11. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Swedish Colorectal Cancer Registry: an overview of completeness, timeliness, comparability and validity.
Moberger P; Sköldberg F; Birgisson H
Acta Oncol; 2018 Dec; 57(12):1611-1621. PubMed ID: 30477372
[TBL] [Abstract][Full Text] [Related]
13. Completeness of American Cancer Registry Treatment Data: implications for quality of care research.
Mallin K; Palis BE; Watroba N; Stewart AK; Walczak D; Singer J; Barron J; Blumenthal W; Haydu G; Edge SB
J Am Coll Surg; 2013 Mar; 216(3):428-37. PubMed ID: 23357724
[TBL] [Abstract][Full Text] [Related]
14. Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway.
Tingulstad S; Halvorsen T; Norstein J; Hagen B; Skjeldestad FE
Int J Cancer; 2002 Apr; 98(6):907-11. PubMed ID: 11948471
[TBL] [Abstract][Full Text] [Related]
15. How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?
Diamond C; Taylor TH; Im T; Wallace M; Saven A; Anton-Culver H
Cancer Causes Control; 2007 Mar; 18(2):135-42. PubMed ID: 17235495
[TBL] [Abstract][Full Text] [Related]
16. Validation of electronic data on chemotherapy and hormone therapy use in HMOs.
Ritzwoller DP; Carroll N; Delate T; O'Keeffe-Rossetti M; Fishman PA; Loggers ET; Aiello Bowles EJ; Elston-Lafata J; Hornbrook MC
Med Care; 2013 Oct; 51(10):e67-73. PubMed ID: 22531648
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunization data completeness within a large community health care system exchanging data with a state immunization information system.
Hendrickson BK; Panchanathan SS; Petitti D
J Public Health Manag Pract; 2015; 21(3):288-95. PubMed ID: 24378608
[TBL] [Abstract][Full Text] [Related]
18. Assessing the validity of tuberculosis surveillance data in California.
Sprinson JE; Lawton ES; Porco TC; Flood JM; Westenhouse JL
BMC Public Health; 2006 Aug; 6():217. PubMed ID: 16930492
[TBL] [Abstract][Full Text] [Related]
19. Completeness of case ascertainment at the Irish National Cancer Registry.
O'Brien K; Comber H; Sharp L
Ir J Med Sci; 2014 Jun; 183(2):219-24. PubMed ID: 23955644
[TBL] [Abstract][Full Text] [Related]
20. Systematic failure to operate on colorectal cancer liver metastases in California.
Raoof M; Jutric Z; Haye S; Ituarte PHG; Zhao B; Singh G; Melstrom L; Warner SG; Clary B; Fong Y
Cancer Med; 2020 Sep; 9(17):6256-6267. PubMed ID: 32687265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
